Literature DB >> 24943863

Lower regional and temporal ultraviolet exposure is associated with increased rates and severity of inflammatory bowel disease hospitalisation.

B N Limketkai1, T M Bayless, S R Brant, S M Hutfless.   

Abstract

BACKGROUND: In the northern hemisphere, the incidence of inflammatory bowel diseases (IBD) has a north-south gradient, suggesting a link between ultraviolet (UV) exposure or vitamin D status and the pathogenesis of IBD. AIM: To test the association of UV exposure with the rates and severity of IBD hospitalisation.
METHODS: We conducted a retrospective nationwide analysis of 649 932 Crohn's disease (CD), 384 267 ulcerative colitis (UC), and 288 894 297 non-IBD hospitalisations in the US between 1998 and 2010. Mean UV exposure was assigned to each hospitalisation using surface measures from the National Oceanic and Atmospheric Administration. Relative rates across UV exposures were estimated for IBD hospitalisations, prolonged hospitalisations, bowel surgeries and deaths.
RESULTS: Among IBD patients, lower UV exposures had increased hospitalisation rates for CD (217.8 vs. 182.5 per 100 000 overall hospitalisations with low and very high UV, respectively; P trend <0.001) and UC (123.2 vs. 113.8 per 100 000; P trend = 0.033). Low UV groups had greater relative rates of prolonged hospitalisations [CD: 1.13, 95% confidence interval (CI) 1.07-1.19; UC: 1.21, 95% CI 1.13-1.30], bowel surgeries (CD: 1.24, 95% CI 1.16-1.32; UC: 1.21, 95% CI 1.09-1.33), and CD deaths (CD: 1.76, 95% CI 1.14-2.71; UC: 1.24, 95% CI 0.92-1.67). Among non-IBD patients, low UV was associated with prolonged hospitalisations (1.09; 95% CI 1.07-1.11) and deaths (1.13; 95% CI 1.09-1.17), but not bowel surgeries (1.01; 95% CI 0.99-1.03).
CONCLUSIONS: Lower ultraviolet exposure is associated with greater rates of hospitalisation, prolonged hospitalisation and the need for bowel surgery in IBD. This trend for bowel surgery was not seen with non-IBD encounters.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 24943863     DOI: 10.1111/apt.12845

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  16 in total

1.  Age at onset is associated with the seasonal pattern of onset and exacerbation in inflammatory bowel disease.

Authors:  Manabu Araki; Shinichiro Shinzaki; Takuya Yamada; Shoko Arimitsu; Masato Komori; Narihiro Shibukawa; Akira Mukai; Sachiko Nakajima; Kazuo Kinoshita; Shinji Kitamura; Yoko Murayama; Hiroyuki Ogawa; Yuichi Yasunaga; Masahide Oshita; Hiroyuki Fukui; Eiji Masuda; Masahiko Tsujii; Satoshi Hiyama; Takahiro Inoue; Hideki Iijima; Tetsuo Takehara
Journal:  J Gastroenterol       Date:  2017-02-06       Impact factor: 7.527

2.  Vitamin D Deficiency Associated with Disease Activity in Patients with Inflammatory Bowel Diseases.

Authors:  Mehdi Torki; Ali Gholamrezaei; Leila Mirbagher; Manijeh Danesh; Sara Kheiri; Mohammad Hassan Emami
Journal:  Dig Dis Sci       Date:  2015-06-02       Impact factor: 3.199

Review 3.  Vitamin D and the Pathogenesis of Inflammatory Bowel Disease.

Authors:  Berkeley N Limketkai; Matthew L Bechtold; Douglas L Nguyen
Journal:  Curr Gastroenterol Rep       Date:  2016-10

Review 4.  Influence of environmental factors in the development of inflammatory bowel diseases.

Authors:  Evangelia Legaki; Maria Gazouli
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

Review 5.  Vitamin D: a brief overview of its importance and role in inflammatory bowel disease.

Authors:  Kiran Mudambi; Dorsey Bass
Journal:  Transl Gastroenterol Hepatol       Date:  2018-05-29

Review 6.  The role of UVR and vitamin D on T cells and inflammatory bowel disease.

Authors:  Stephanie Bora; Margherita T Cantorna
Journal:  Photochem Photobiol Sci       Date:  2017-03-16       Impact factor: 3.982

Review 7.  Protective links between vitamin D, inflammatory bowel disease and colon cancer.

Authors:  Stacey Meeker; Audrey Seamons; Lillian Maggio-Price; Jisun Paik
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 8.  Influence of environmental factors on the onset and course of inflammatory bowel disease.

Authors:  Amit Kumar Dutta; Ashok Chacko
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

9.  Emergency department utilisation for inflammatory bowel disease in the United States from 2006 to 2014.

Authors:  S Ballou; W Hirsch; P Singh; V Rangan; J Nee; J Iturrino; T Sommers; J Zubiago; N Sengupta; A Bollom; M Jones; A C Moss; S N Flier; A S Cheifetz; A Lembo
Journal:  Aliment Pharmacol Ther       Date:  2018-02-07       Impact factor: 8.171

Review 10.  Association between 25(OH)D Level, Ultraviolet Exposure, Geographical Location, and Inflammatory Bowel Disease Activity: A Systematic Review and Meta-Analysis.

Authors:  Chao Lu; Jun Yang; Weilai Yu; Dejian Li; Zun Xiang; Yiming Lin; Chaohui Yu
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.